Correlation of levels of early second trimester beta-human chorionic gonadotropin levels with severity of preeclampsia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20223127Keywords:
β-hCG, Preeclampsia, Pregnancy induced hypertension, HDPAbstract
Background: Hypertensive disorders in pregnancy remains a leading cause of maternal morbidity and mortality all over the world as per World Health Organization (WHO), affecting 5-10% of all pregnant women. Screening women at an early stage and preventing complications are corner stone in the management of pre-eclampsia. Several studies have proven the reliability of beta-human chorionic gonadotropin (β-hCG) as predictor of preeclampsia. In this study we aim to find the correlation of increasing levels of β-hCG with severity of preeclampsia.
Methods: In this study serum β-hCG estimation was done in 200 pregnant women between 13 and 20 weeks of gestation, selected randomly over a period of 1 year attending antenatal clinic by quantitative determination of β-hCG by electro-chemiluminescence immunoassay. Multiple of median (MOM) is calculated from charts of norms available. They were followed till delivery for development of pre-eclampsia. The following patients were followed up till delivery. Blood parameters, blood pressure readings, were done at 34 weeks for every patient and maternal complications were noted and results were analysed statistically.
Results: The incidence of preeclampsia in this study population was 8% (16 out of 200). This study found a significant correlation between increasing levels of MOM’s of β-hCG with the severity of preeclampsia.
Conclusions: In this study, there was significant association between MOM values of β-hCG with the parameters defining severity of preeclampsia. The results of our study show β-hCG to be not only a reliable marker for prediction of preeclampsia, but also its severity.
Metrics
References
Cunnnigham FG, Leveno KL, Bloom SL Hauth JC, Gilstrap LC and Wenstrom KD, Hypertensive disorder in pregnancy. In: cunnigham FG, Leveno KL. Bloom SL, editors. Williamsobstertrics. 22nd edition. NewYork, McGraw-Hill. 2005;34:1237.
Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002;287(24):3183-6.
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatal. 2009;33(3):130-7.
Sibai BM, Caritis S, Hauth J. What we have learned about preeclampsia. Semin Perinatol. 2003;27(3):239-46.
Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002;287(24):3183-6.
Lindheimer MD, Taylor RN, Cunningham FG. Introduction, history, controversies, and definitions. In Taylor RN, Roberts JM, Cunningham FG (eds): Chesley’s Hypertensive Disorders in Pregnancy, 4th ed, Amsterdam, Academic Press. 2014.
Redman CW, Sargent IL, Taylor RN. Immunology of abnormal pregnancy and preeclampsia. In Taylor RN, Roberts JM, Cunningham FG (eds): Chesley’s Hypertensive Disorders in Pregnancy, 4th ed. Amsterdam, Academic Press. 2014.
Duric K, Skrablin S, Lesin J, Kalafatic D, Kuvacic I, Suchanek E. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):12-5.
Freemark M. Placental hormones and the control of fetal growth. J Clin Endocrinol Metab. 2010;95:2054.
Luckas M, Hawe J, Meekins J, Neilson J, Walkinshaw S. Second trimester serum free β human chorionic gonadotrophin levels as a predictor of pre-eclampsia. Acta Obstet Gynecol Scand. 1998;77(4):381-4.
Cole LA, Kardana A, Park SY, Braunstein GD. The deactivation of hCG by nicking and dissociation. J Clin Endocrinol Metab. 1993;76(3):7.
Lindheimer MD, Conrad K, Karumanchi SA. Renal physiology and disease in pregnancy. In Alpern RJ, Hebert SC (eds): Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology, 4th ed. New York, Elsevier. 2008;2339.
Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, Catalano PM, Morris CD. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol. 2000;95(1):24-8.
World Health Organization. World Health Report 2005: make every mother and child count. Geneva: WHO. 2005;63.
Thillaigovindan R, Chandran PJ, Babu S. Prosthetic Rehabilitation of a Patient with Ectodermal Dysplasia - A Case Report. J Dent Med Sci. 2014;13(7):28-31.
Kaur G, Jain V, Mehta S, Himani S. Prediction of PIH by Maternal Serum Beta HCG Levels in the Second Trimester (13-20 Weeks) of Pregnancy. J Obstet Gynaecol India. 2012;62(1):32-4.
Desai P, Rao S. Predictive value of raised midtrimester beta HCG in PIH. J Obstet Gynaecol India. 2002;52:68-70.
Roiz-Hernandez J, de Cabello-Martinez J, Fernandez Mejia M. Human chorionic gonadotropin levels between 16 and 21 weeks of pregnancy and prediction of pre-eclampsia. Int J Gynaecol Obstet. 2006;92:101-5.
Kabukcu A, LutfuOnderoglu S, Laheli Y. Women with elevated second trimester human chorionic gonadotropin level are at increased risk for preeclampsia. Turk J Med Sci. 1998;28:273-6.
Jaiswar SP, Nisha, Mamta R. Maternal serum human chorionic gonadotropin as a predictor for pregnancy induced hypertension. J Obstet Gynecol India. 2003;53:543-5.
